CIMChimera Investment Corporation

$8.43-29% 1Y

Is the price fair?

Mixed

In its normal P/E range. That is the only one of 3 checks this filer's data supports, so take it as a single data point rather than a settled answer.

1 neutral, 2 without data
Vs its own P/E rangemid-range for this companyderived

In its normal range: P/E 7.0 vs a 7.0 median over 18 quarters (−0% vs median).

Where this answer is blind. The growth-implied estimate assumes a fixed discount rate; capital-heavy sectors look structurally rich on it.

What CIM's price assumes

Chimera Investment Corporation has no trailing P/E on file, so the price is measured against sales instead: 4.04× revenue.

4.04

Price / sales · no trailing P/E on file: measured against sales instead

Price / book
0.46

Price / book · as of 2026-Q2

EV / sales
3.35

EV / sales

Details›
Price / bookas of 2026-Q2
0.46
EV / salesas of 2026-Q2
3.35
Market capitalisation83.7 million shares, counted Jul 31, 2026
$706M

Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.